Aayush Food & Herbs Ltd.
Snapshot View

28.35 -0.75 ▼-2.6%

23 July 2021, 04:00:00 P.M.
Volume: 3,323

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aayushfoods.com
Financial Indicators
Market Cap 9.20 Cr.
Earnings per share (EPS) -2.13 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-06
Industry PE 35.17 Trailing Twelve Months Ending 2021-06
Book Value / Share 18.02 Trailing Twelve Months Ending 2021-06
Price to Book Value 1.57 Calculated using Price: 28.35
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.32 Cr. 3,245,000 Shares
FaceValue 10
Company Profile

Aayush Food & Herbs is a public listed company incorporated in the year 1984 having its registered office at Chirag Delhi, New Delhi. The company’s equity shares are listed on BSE and Metropolitan Stock Exchange.

Aayush Food & Herbs is exporting various varieties of finest rice to many countries with major chunk in parts of West Africa. On other side, the company is strengthening the distribution network through dealers, agents, companies etc. in home country. The company is taking significant measures to ensure continued strong growth through a combination of investments in distribution expansion. The company has commenced operations of trading and export of rice during last quarter of Financial Year 2015-16 and the company’s decision is promising in view of industry outlook.

Business area of the company

The company is exporting various varieties of finest rice to many countries with major chunk in parts of West Africa. It is strengthening the distribution network through dealers, agents, companies etc. in home country.


Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-2.58%
1 Week
-7.95%
1 Month
-7.05%
3 Month
+0.53%
6 Month
-12.09%
1 Year
-41.18%
2 Year
+73.93%
5 Year
+65.79%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 2.66 0.31 0.82 -0.62 2.06 7.68 14.04 11.05 10.26
Return on Capital Employed (%) 3.58 0.73 0.50 -0.87 2.08 12.11 23.18 20.33 14.99
Return on Assets (%) 0.79 0.25 0.82 -0.62 1.75 3.05 2.30 1.55 1.52

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 0 0 0 4 4 4 5 6 6
Non Curr. Liab. 0 0 0 0 1 0 1 12
Curr. Liab. 0 1 11 37 29 29
Minority Int.
Equity & Liab. 0 0 0 4 6 16 43 35 46
Non Curr. Assets 0 0 0 0 0 0 1 1 1
Curr. Assets 0 0 0 4 5 16 41 34 45
Misc. Exp. not W/O
Total Assets 0 0 0 4 6 16 43 35 46

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 4 0 0 0 5 100 188 132 127
Other Income 0 0 0 0 0 0 0 1 0
Total Income 4 0 0 0 5 100 188 133 127
Total Expenditure -4 0 0 0 -5 -100 -187 -132 -126
PBIDT 0 0 0 0 0 1 1 1 2
Interest 0 0 0 -1
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 1 1 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 -4 0 -1 6 -3 -10
Cash Fr. Inv. 0 -1 0 0
Cash Fr. Finan. 0 4 1 -1 1 11
Net Change 0 0 0 0 4 -2 1
Cash & Cash Eqvt 0 0 0 0 5 3 3

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 51.28 51.28 51.28 51.28 51.28 45.74 51.28 51.28 51.28
Public 48.72 48.72 48.72 48.72 48.72 54.26 48.72 48.72 48.72
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 20 Jul 2021
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to SEBI circular- CIR/CFD/CMD1/162/2019 dated 24 December 2019 regarding Statement of Deviation or Variation for proceeds of public issue/rights issue/preferential issue Qualified Institutions Placement (QIP) etc. in reference to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that the said Regulation 32(1) is not applicable for the Company as we have not raised funds and hence not submitting Annexure A as per the SEBI circular.

This is for your information and necessary records.
Tue, 20 Jul 2021
Website Undertaking
We hereby state that website of the Company (viz. www.aayushfoods.com) is functional and updated in accordance with SEBI (LODR) Regulations 2015.

Kindly take the same on your records.
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021
Aayush Food and Herbs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here

Technical Scans View Details

Fri, 23 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Both SRS And ARS Below Zero Both SRS And ARS Below Zero
PSAR Indicating Bearish Reversal PSAR Indicating Bearish Reversal
Thu, 22 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 694.00 +1.0%
Divi's Laboratories Ltd. 128,088.59 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,420.50 +0.7%
Cipla Ltd. 76,510.04 948.50 -0.1%
Cadila Healthcare Ltd. 62,965.29 615.05 -0.9%
Aurobindo Pharma Ltd. 56,484.48 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,915.00 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 31.81 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,915.00 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 4.17 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,915.00 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 0.18 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 10.09 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 12.53 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,915.00 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 17,131.99 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,915.00 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 1,546.98 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,915.00 -1.8%